Letters
Release of Avastin
Marketing regulations do not apply to individual clinicians
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2071 (Published 21 April 2015) Cite this as: BMJ 2015;350:h2071
- Stephen J W Evans, professor of pharmacoepidemiology1
- 1Medical Statistics, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
- stephen.evans{at}Lshtm.ac.uk
The “licensing” process generally works well to protect patients from drug companies that promote ineffective or unsafe products.1 This regulatory system is not intended to, and should not, regulate clinical practice. In the UK the General Medical Council has applied the industry regulation system to clinical practice, thus …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.